This post has been archived and contains information that may be out of date.
This week, CHA shared two letters with the Office of Health Care Affordability (OHCA).
The first asks for significant additional amendments to the revised Oct. 9 version of the cost and market impact review regulations. The second provides considerations for OHCA as it begins developing the spending targets that will ultimately limit how much hospital revenues may grow.
The latter letter also continues to argue that OHCA must account for differences in the clinical risks of different providers’ patient populations and for a transparent and robust methodology for attributing patient spending to individual providers.
